Dinc, ErdemAyaz, LokmanKurt, Akif Hakan2024-06-122024-06-1220170271-36831460-2202https://doi.org/10.1080/02713683.2017.1368085https://hdl.handle.net/20.500.14551/18183Purpose: This study aimed to evaluate the protective effects of caffeic acid phenethyl ester (CAPE) and combined CAPE-bevacizumab against oxidative stress induced by hydrogen peroxide (H2O2) in human retinal pigment epithelium. Methods: ARPE-19 cells were pretreated with 5, 10, and 30 mu M CAPE alone and in combination with bevacizumab for 3 h, then exposed to H2O2 for 16 h. Cell viability was evaluated with the 3-(4,5dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Vascular endothelial growth factor (VEGF) protein levels in the medium were measured using a human VEGF ELISA kit. Total antioxidant status (TAS) and total oxidant status (TOS) were measured in ARPE-19 cells using the test kit from Rel Assay. Expression levels of VEGF, Bax, Bcl-2, cytochrome c, apoptotic protease activating factor-1 (apaf-1), and caspase-3 were determined using reverse transcription polymerase chain reaction. Results: Pretreatment of ARPE-19 cells with 30 mu M CAPE and combined CAPE-bevacizumab reduced H2O2 mediated cell death. H2O2-induced oxidative stress increased TOS and VEGF production, which was significantly inhibited by CAPE and the CAPE-bevacizumab combination. VEGF, Bax, cytochrome c, apaf-1, and caspase-3 gene expressions were significantly decreased in cells pretreated with 5, 10, and 30 mu M CAPE and combined CAPE-bevacizumab compared to the H2O2 group. In addition, Bcl-2 expression was significantly increased in both the CAPE and CAPE-bevacizumab combination groups compared to the H2O2 group. Conclusions: CAPE has a protective effect on ARPE-19 cells against oxidative stress, and VEGF protein level and expression can be decreased by incubation with different concentrations of CAPE. These results demonstrate that CAPE suppresses the mitochondria-mediated apoptosis in ARPE-19 cells under oxidative stress. In addition, the use of CAPE in combination with bevacizumab has an additive effect.en10.1080/02713683.2017.1368085info:eu-repo/semantics/closedAccessAge Related Macular DegenerationBevacizumabCaffeic Acid Phenethyl EsterCAPEOxidative StressRetinal Pigment EpitheliumEndothelial Growth-FactorPigment Epithelial-CellsMacular DegenerationCytochrome-CApoptosisBaxExpressionReleaseRatsNeovascularizationArticle421216591666Q2WOS:0004228534000152-s2.0-8502989960828937872Q2